Prognostic values of perfusion-metabolic mismatch in Tl-01 and BMIPP scintigraphic imaging in patients with chronic coronary artery disease and left ventricular dysfunction undergoing revascularization

Annals of Nuclear Medicine

Volumn 16, Issue 2, 2002, Pages 109-115

  Fukuzawa, Shigeru ^a   Ozawa, Shun ^a   Shimada, Kazuhiro ^a   Sugioka, Juji ^a   Inagaki, Masayuki ^a  

^a Funabashi Municipal Medical Center   (Japan)

Author keywords

Fatty acid metabolism; Left ventricular dysfunction; Long term prognosis; Revascularization; Viability

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; THALLIUM 201; DIAGNOSTIC AGENT; FATTY ACID; IODOBENZENE; IODOFILTIC ACID; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; THALLIUM;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICULOGRAPHY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL TIME; CORONARY ARTERY ATHEROSCLEROSIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; METABOLISM; MIDDLE AGED; SCINTISCANNING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FATTY ACIDS; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036001350     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02993713     Document Type: Article

References (25)

1. Late reversibility of tomographic myocardial thallium-201 defects: An accurate marker of myocardial viability
2. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging
3. Quantitative planar rest-redistribution Tl-201 imaging in the detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function
4. Dobutamine echocardiography and rest-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization
5. Effects of myocardial revascularization on regional thallium-201 up-take and systolic function in regions with reverse redistribution on tomographic thallium-201 at rest patients with chronic coronary artery disease
6. Cardiac SPECT with iodine-123-labeled fatty acids: Evaluation of myocardial viability with BMIPP
7. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model
8. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium
9. An effective tool to detect lesions causing unstable angina with multivessel disease: Iodine-123 beta-methyl-p-iodophenyl pentadecanoic acid single photon emission computed tomography
10. Concordance and disconcordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium: Comparison with metabolic activity by positron emission tomography
11. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction
12. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP
13. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction
14. Myocardial accumulation of iodinated beta-methyl branched fatty acid analog, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl-pentadecanoic acid (BMIPP), in relation to ATP concentration
15. Radionuclide assessment of stunned myocardium by alterations in perfusion, metabolic and wall motion
16. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog
17. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: Assessment with dynamic rest and stress images compared with stress thallium-201 SPECT
18. Combined study with 1-123 fatty acid and thallium-201 to assess ischemic myocardium: Comparison with thallium redistribution and glucose metabolism
19. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization
20. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
21. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
22. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
23. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
24. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization
25. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium